Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis
NCT03006874
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
302
Enrollment
INDUSTRY
Sponsor class
Conditions
Erosive Esophagitis
Interventions
DRUG:
CJ-12420 100mg QD
DRUG:
Esomeprazole 40mg
DRUG:
CJ-12420 50mg QD
Sponsor
HK inno.N Corporation